Holen Sie sich die Stockscreener-App
74.81
0.15%
0.11
Handel nachbörslich:
74.81
Schlusskurs vom Vortag:
$74.70
Offen:
$74.81
24-Stunden-Volumen:
3.03M
Relative Volume:
1.07
Marktkapitalisierung:
$16.70B
Einnahmen:
$4.04B
Nettoeinkommen (Verlust:
$557.10M
KGV:
31.04
EPS:
2.4102
Netto-Cashflow:
$916.70M
1W Leistung:
-0.16%
1M Leistung:
-0.13%
6M Leistung:
+11.84%
1J Leistung:
+14.30%
1-Tages-Spanne:
$74.81
$74.97
1-Wochen-Bereich:
$74.50
$75.00
52-Wochen-Spanne:
$51.90
$75.36
Hologic Inc Stock (HOLX) Company Profile
Firmenname
Hologic Inc
Sektor
Telefon
(508) 263-2900
Adresse
250 CAMPUS DRIVE, MARLBOROUGH, MA
Compare HOLX vs ISRG, BDX, RMD, MDLN, ALC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
74.81 | 16.68B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
488.15 | 169.16B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
210.05 | 58.84B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
RMD
Resmed Inc
|
271.63 | 38.90B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
47.30 | 38.45B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
ALC
Alcon Inc
|
78.83 | 38.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-12 | Herabstufung | Argus | Buy → Hold |
| 2026-01-05 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-11-21 | Herabstufung | BNP Paribas Exane | Outperform → Neutral |
| 2025-10-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-08-18 | Hochstufung | Argus | Hold → Buy |
| 2025-08-06 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-05-27 | Bestätigt | Needham | Hold |
| 2025-03-03 | Herabstufung | Argus | Buy → Hold |
| 2025-02-06 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Herabstufung | Needham | Buy → Hold |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-12-10 | Bestätigt | Needham | Buy |
| 2024-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-06-27 | Eingeleitet | Stephens | Overweight |
| 2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-14 | Hochstufung | Needham | Hold → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-07-20 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-07-18 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-10-14 | Eingeleitet | Redburn | Neutral |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Herabstufung | Needham | Buy → Hold |
| 2020-11-05 | Bestätigt | Needham | Buy |
| 2020-06-30 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-06-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Bestätigt | Needham | Buy |
| 2020-04-30 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Bestätigt | Needham | Buy |
| 2019-05-02 | Bestätigt | Needham | Buy |
| 2019-01-31 | Bestätigt | Needham | Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Eingeleitet | UBS | Neutral |
| 2018-09-13 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Hologic Inc Aktie (HOLX) Neueste Nachrichten
Hologic, Inc. (HOLX) Announces Shareholder Approval for Merger w - GuruFocus
Hologic Shareholders Approve Blackstone and TPG Buyout Deal - TipRanks
SA's Competition Commission approves proposed deal whereby Hopper parent intends to buy Hologic, without conditions - marketscreener.com
Hologic’s Aptima assay secures FDA approval for HPV primary screening - Medical Device Network
Hologic’s Aptima HPV assay receives FDA approval for primary screening By Investing.com - Investing.com Nigeria
Hologic Goes Global: Can International Expansion Offset China and Africa Headwinds? - Smartkarma
FDA Approves Hologic’s Aptima HPV Assay Primary Screening Option - Medical Product Outsourcing
Hologic receives FDA approval for Aptima® HPV assay primary screening option, expanding cervical health portfolio - marketscreener.com
Hologic Says US FDA Approves Aptima HPV Testing Assay - marketscreener.com
Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health PortfolioHologic, Inc. - Hologic, Inc. - Investor Relations
United States Bone Densitometer Devices Market is expected - openPR.com
Robert Olstein's Strategic Moves: Exiting Hologic Inc with a -1.44% Impact - Yahoo Finance
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
Hologic, Inc. (HOLX) is attracting investor attention: Here is what you should know - MSN
Hologic (HOLX) International Revenue Performance Explored - Yahoo Finance
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Hologic, Inc. (HOLX) Stock Analysis: Unpacking Growth Potential Amidst a Hold Rating Consensus - DirectorsTalk Interviews
Is Hologic Inc vulnerable to short sellersMarket Activity Summary & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
(HOLX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Market Outlook: What are analysts price targets for Hologic Inc2025 Price Momentum & Weekly Top Performers Watchlists - baoquankhu1.vn
Hologic (HOLX) Q1 2026 Margin Compression Reinforces Cautious Community Narratives - Sahm
Evercore ISI Adjusts Hologic Price Target to $76 From $78, Maintains In Line Rating - marketscreener.com
Hologic Q1 comes up short of Street expectations ahead of sale to private equity - MassDevice
HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash - tradingview.com
Decoding Hologic Inc (HOLX): A Strategic SWOT Insight - GuruFocus
Compared to Estimates, Hologic (HOLX) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Hologic (NASDAQ:HOLX) Misses Q4 CY2025 Revenue Estimates - Finviz
Hologic (HOLX) Misses Q1 Earnings and Revenue Estimates - Yahoo Finance
Setup Watch: Does Hologic Inc have a sustainable dividendForecast Cut & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Hologic: Fiscal First Quarter Earnings Overview - Bitget
Hologic (HOLX) Faces Legal Challenges Amid Merger and Product Re - GuruFocus
Hologic Fiscal Q1 Adjusted Earnings, Revenue Rise - marketscreener.com
Hologic: Fiscal Q1 Earnings Snapshot - kare11.com
Hologic misses Q1 earnings and revenue estimates, shares edge lower By Investing.com - Investing.com Nigeria
Hologic misses Q1 earnings and revenue estimates, shares edge lower - Investing.com
Hologic Announces Financial Results for First Quarter of Fiscal 2026 - TradingView
Hologic earnings missed by $0.05, revenue fell short of estimates - Investing.com Canada
HOLOGIC INC SEC 10-Q Report - TradingView
What you need to know ahead of Hologic's earnings release - MSN
Examining the Future: Hologic's Earnings Outlook - Benzinga
Why Analysts Are Rethinking The Story Behind Hologic (HOLX) After New Price Targets - Yahoo Finance
Hologic (HOLX) Q4 Earnings: What To Expect - Finviz
Hologic Earnings Report Q1 2026: Analyst Forecasts & Stock OutlookNews and Statistics - IndexBox
HOLOGIC Q1 2026 Earnings Preview: Recent $HOLX Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Assessing Hologic (HOLX) Valuation As Shares Hover Near Analyst Fair Value Estimates - Yahoo Finance
Hologic stock hits 52-week high at 75.34 USD By Investing.com - Investing.com Canada
Hologic stock hits 52-week high at 75.34 USD - Investing.com
Hologic Faces Merger-Related Stockholder Suits, Issues Disclosures - TipRanks
Hologic (NASDAQ: HOLX) warns lower CVR value after Brevera recall in Blackstone–TPG buyout - stocktitan.net
Stay Ahead of the Game With Hologic (HOLX) Q1 Earnings: Wall Street's Insights on Key Metrics - Yahoo Finance
The Truth About Hologic Inc: Why This ‘Boring’ Stock Could Be a Silent Game-Changer - AD HOC NEWS
Finanzdaten der Hologic Inc-Aktie (HOLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):